Search

Your search keyword '"Nguyen-Khac, Eric"' showing total 406 results

Search Constraints

Start Over You searched for: Author "Nguyen-Khac, Eric" Remove constraint Author: "Nguyen-Khac, Eric"
406 results on '"Nguyen-Khac, Eric"'

Search Results

1. Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective study

3. International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations

6. Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis

7. Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort

8. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

11. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

12. Large-scale screening of lipase acid deficiency in at risk population

13. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma

14. Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

18. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

19. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy

20. Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

21. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

23. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors

24. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis

25. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

26. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis

27. The epidemiology of Budd–Chiari syndrome in France

28. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

29. Hépatite alcoolique aiguë sévère

30. Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis

31. Data from BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

32. Supplementary Data from BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

34. Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis

35. Management of alcohol‐related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines

37. Cabozantinib (CABO) tolerance and efficacy for patients with advanced hepatocellular carcinoma (HCC) after failure of sorafenib (SOR) in a French population: CLERANCE, a phase 4 trial.

38. Germline Mutations of Telomere-Related Genes are a Major Risk Factor for Liver Disease: A Multicentric Transversal Study

39. ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

41. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study

42. Correction: Endoscopic treatment of large gastric leaks after gastrectomy using the combination of double pigtail drains crossing a covered stent

43. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation

44. Liver Stiffness by Transient Elastography to Detect Porto‐Sinusoidal Vascular Liver Disease With Portal Hypertension

47. Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

48. Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO.

49. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

Catalog

Books, media, physical & digital resources